335 related articles for article (PubMed ID: 9740093)
21. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
[TBL] [Abstract][Full Text] [Related]
22. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB
Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986
[TBL] [Abstract][Full Text] [Related]
23. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
24. [Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
Akiyama H; Kunisaki C; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2168-73. PubMed ID: 12484029
[TBL] [Abstract][Full Text] [Related]
25. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot.
van der Vange N; van Goethem AR; Zoetmulder FA; Kaag MM; van de Vaart PJ; ten Bokkel Huinink WW; Beijnen JH
Eur J Surg Oncol; 2000 Nov; 26(7):663-8. PubMed ID: 11078613
[TBL] [Abstract][Full Text] [Related]
26. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
Panteix G; Beaujard A; Garbit F; Chaduiron-Faye C; Guillaumont M; Gilly F; Baltassat P; Bressolle F
Anticancer Res; 2002; 22(2B):1329-36. PubMed ID: 12168946
[TBL] [Abstract][Full Text] [Related]
28. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
Gilly FN; Beaujard A; Glehen O; Grandclement E; Caillot JL; Francois Y; Sadeghi-Looyeh B; Gueugniaud PY; Garbit F; Benoit M; Bienvenu J; Vignal J
Anticancer Res; 1999; 19(3B):2317-21. PubMed ID: 10472351
[TBL] [Abstract][Full Text] [Related]
29. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.
Bevanda M; Orsolic N; Basic I; Vukojevic K; Benkovic V; Horvat Knezevic A; Lisicic D; Dikic D; Kujundzic M
Int J Hyperthermia; 2009 Mar; 25(2):132-40. PubMed ID: 19337913
[TBL] [Abstract][Full Text] [Related]
30. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
31. Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.
Posner MC; Lienard D; Lejeune FJ; Rosenfelder D; Kirkwood J
Cancer J Sci Am; 1995; 1(4):274-80. PubMed ID: 9166488
[TBL] [Abstract][Full Text] [Related]
32. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
[TBL] [Abstract][Full Text] [Related]
33. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.
Miao N; Pingpank JF; Alexander HR; Royal R; Steinberg SM; Quezado MM; Beresnev T; Quezado ZM
Ann Surg Oncol; 2009 Feb; 16(2):334-44. PubMed ID: 19050961
[TBL] [Abstract][Full Text] [Related]
35. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of gastric cancer patients with peritoneal metastasis by continuous hyperthermic peritoneal infusion with mitomycin C and cisplatin].
Yonemura Y; Fujimura T; Takekawa S; Ohoyama S; Kimura H; Kamata T; Katayama K; Matsuki N; Sawa T; Sakuma H
Gan To Kagaku Ryoho; 1991 Feb; 18(2):271-6. PubMed ID: 1899549
[TBL] [Abstract][Full Text] [Related]
38. Continuous hyperthermic peritoneal perfusion for peritoneal dissemination of gastric cancer.
Akiyama H; Yamaoka H; Tanaka K; Ishikawa T; Ichikawa Y; Wakasugi J; Nagashima Y; Shimada H
Hepatogastroenterology; 1998; 45(24):2079-86. PubMed ID: 9951869
[TBL] [Abstract][Full Text] [Related]
39. Hyperthermic antiblastic perfusion with TNFalpha and melphalan in stage III limb melanoma patients: A phase I - II SITILO study.
Di Filippo F; Rossi CR; Garinei R; Anzà M; Cavaliere F; Botti C; Perri P; Di Filippo S; Di Angelo P; Principi F; Laurenzi L
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):97-101. PubMed ID: 16767914
[TBL] [Abstract][Full Text] [Related]
40. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
